Description
Ragifilimab (INCAGN-1876) is an agonist monoclonal antibody targeting the glucocorticoid-induced TNFR-related protein (GITR). Ragifilimab can be used for advanced or metastatic solid tumors research.
Cat.No
A566
Name
Ragifilimab
Chemical Properties
CAS
2207590-51-8
Synonyms
Ragifilimab;Research Grade Ragifilimab (DHJ89801);Ragifilimab (anti-TNFRSF18);Ragifilimab (anti-TNFRSF18);Ragifilimab (anti-TNFRSF18);Ragifilimab (anti-TNFRSF18);INCAGN-01876|||INCAGN-1876|||CM-701;INCAGN-01876|||INCAGN-1876|||CM-701;INCAGN-01876|||INCAGN-1876|||CM-701;INCAGN-01876|||INCAGN-1876|||CM-701
pH value
Corresponds to reference standard: PASS
Non-reduced CE-SDS
>95%
SEC-HPLC
>95%
Isoelectric Point
Corresponds to reference standard
Bacterial Endotoxins Test
Residual Proteins of Host Cell
Exogenous Residual DNA
Residual protein A
Biological Activity
Osmolality
Corresponds to reference standard: PASS
Peptide mapping
Corresponds to reference standard: PASS
N-terminal sequence
Corresponds to reference standard: PASS
References
Return Policy
If you are in any way unsatisfied with your purchase, you may return any item(s) within 365 days of its original purchase date.
Please provide your Order Number in the email. We strive to reply to all email inquiries within one business day.
Tel: +86-21-58447131Fax: +86-21-61642470Email:
Website:
